Document is current
Any future updates will be listed below
-
Authors
Park, Jongjun
Bae, Tae Hui
Kim, Su Yong
Park, Seongeun
Choi, Yonghyun
Tanaka, Masayoshi
Kim, Jiwon
Jang, Jaehee
Yang, Jihyuk
Lee, Hee-Young
Niepa, Tagbo H. R.
Kang, Shin Hyuk
Choi, Jonghoon https://orcid.org/0000-0003-3554-7033
-
Funding
Funding for this research was provided by:
NRF Korea (RS-2024-00343605)
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 25 April 2025
First Online: 14 May 2025
Declarations
:
: This study was conducted in accordance with all relevant ethical guidelines and regulations, adhering to the principles of the ‘3Rs’ (Replacement, Reduction, and Refinement) of animal research. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Chung-Ang University Hospital (IACUC 202301020138), and every effort was made to minimize animal discomfort and distress throughout the experiment.
: Dr. Jonghoon Choi is the CEO/Founder and Dr. Yonghyun Choi is the CTO of the Feynman Institute of Technology at the Nanomedicine Corporation and Mr. Jongjun Park is a researcher at the Feynman Institute of Technology.
